StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AQST

Aquestive Therapeutics, Inc.

AQST Nasdaq Pharmaceutical Preparations EDGAR ↗
$3.79
+0.07 +1.88%

Key statistics

from XBRL data in SEC filings
Market cap
$475M
Revenue (TTM)
$50.3M
Net income (TTM)
-$68.9M
EPS (TTM)
$-0.61
P/E ratio
Dividend yield
Free cash flow
-$53.0M
Cash
$111M
Total assets
$141M
Gross margin
52-week range
$2.93 – $7.55

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 10, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure May 13, 2026 8-K Regulation FD disclosure Mar 30, 2026 8-K Director or officer change; Regulation FD disclosure Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Mar 4, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Regulation FD disclosure Feb 2, 2026 8-K Other events Jan 9, 2026 8-K Regulation FD disclosure Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 5, 2025 8-K Other events Oct 8, 2025 8-K Regulation FD disclosure Oct 1, 2025 8-K Regulation FD disclosure Sep 8, 2025 8-K Regulation FD disclosure Sep 4, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 15, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Other events Jul 15, 2025 8-K Regulation FD disclosure Jun 16, 2025 8-K Shareholder vote results Jun 11, 2025 8-K Regulation FD disclosure Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2025 8-K Regulation FD disclosure Apr 1, 2025 8-K Regulation FD disclosure Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2025 8-K Other events Feb 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Other events Dec 19, 2024 8-K Regulation FD disclosure; Other events Dec 2, 2024 8-K Director or officer change Nov 7, 2024 8-K Regulation FD disclosure Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2024 8-K Other events Oct 25, 2024